{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:09:29Z","timestamp":1778998169808,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10067-018-4288-7","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T01:38:11Z","timestamp":1537234691000},"page":"495-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Beh\u00e7et disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Selcan","family":"\u00d6zg\u00fc\u00e7l\u00fc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00fcrker","family":"Duman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda Seher \u00d6zalp","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"K\u00fc\u00e7\u00fck\u015fahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"\u00c7olak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00dcmit","family":"\u00d6lmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"issue":"2","key":"4288_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","volume":"167","author":"E Bouali","year":"2015","unstructured":"Bouali E, Kaabachi W, Hamzaoui A, Hamzaoui K (2015) Interleukin-37 expression is decreased in Beh\u00e7et\u2019s disease and is associated with inflammation. Immunol Lett 167(2):87\u201394. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2015.08.001","journal-title":"Immunol Lett"},{"key":"4288_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2018.03.016","volume":"192","author":"O Kacem","year":"2018","unstructured":"Kacem O, Kaabachi W, Dhifallah IB, Hamzaoui A, Hamzaoui K (2018) Elevated expression of TSLP and IL-33 in Beh\u00e7et\u2019s disease skin lesions: IL-37 alleviate inflammatory effect of TSLP. Clin Immunol 192:14\u201319. \n                    https:\/\/doi.org\/10.1016\/j.clim.2018.03.016","journal-title":"Clin Immunol"},{"issue":"5","key":"4288_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00296-014-3171-3","volume":"35","author":"EE \u0130nal","year":"2015","unstructured":"\u0130nal EE, R\u00fcstemo\u011flu A, \u0130nan\u0131r A, Ekinci D, G\u00fcl \u00dc, Yi\u011fit S, Ate\u015f \u00d6 (2015) Associations of rs4810485 and rs1883832 polymorphisms of CD40 gene with susceptibility and clinical findings of Beh\u00e7et\u2019s disease. Rheumatol Int 35(5):837\u2013843. \n                    https:\/\/doi.org\/10.1007\/s00296-014-3171-3","journal-title":"Rheumatol Int"},{"key":"4288_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/1566524014666140414210831","volume":"14","author":"Z Ye","year":"2014","unstructured":"Ye Z, Wang C, Kijlstra A, Zhou X, Yang P (2014) A possible role for interleukin 37 in the pathogenesis of Beh\u00e7et\u2019s disease. Curr Mol Med 14:535\u2013542","journal-title":"Curr Mol Med"},{"issue":"5","key":"4288_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/eji.201545828","volume":"46","author":"CA Dinarello","year":"2016","unstructured":"Dinarello CA, Nold-Petry C, Nold M, Fujita M, Li S, Kim S, Bufler P (2016) Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol 46(5):1067\u20131081. \n                    https:\/\/doi.org\/10.1002\/eji.201545828","journal-title":"Eur J Immunol"},{"issue":"6","key":"4288_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.smim.2013.10.001","volume":"25","author":"CA Dinarello","year":"2013","unstructured":"Dinarello CA, Bufler P (2013) Interleukin-37. Semin Immunol 25(6):389\u2013393. \n                    https:\/\/doi.org\/10.1016\/j.smim.2013.10.004","journal-title":"Semin Immunol"},{"issue":"4","key":"4288_CR7","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.3892\/ol.2018.7982","volume":"15","author":"L Wang","year":"2018","unstructured":"Wang L, Quan Y, Yue Y, Heng X, Che F (2018) Interleukin-37: a crucial cytokine with multiple roles in disease and potentially clinical therapy. Oncol Lett 15(4):4711\u20134719. \n                    https:\/\/doi.org\/10.3892\/ol.2018.7982","journal-title":"Oncol Lett"},{"issue":"1","key":"4288_CR8","doi-asserted-by":"publisher","first-page":"e0169922","DOI":"10.1371\/journal.pone.0169922","volume":"12","author":"H Liu","year":"2017","unstructured":"Liu H, Zheng R, Wang P, Yang H, He X, Ji Q, Bai W, Chen H, Chen J, Peng W, Liu S, Liu Z, Ge B (2017) IL-37 confers protection against mycobacterial infection involving suppressing inflammation and modulating T cell activation. PLoS One 12(1):e0169922. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0169922","journal-title":"PLoS One"},{"issue":"1","key":"4288_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1995-7645(12)60204-1","volume":"6","author":"LP Shi","year":"2013","unstructured":"Shi LP, He Y, Liu ZD (2013) Correlation between single nucleotide polymorphism of rs 3811047 in IL-1 F7 gene and rheumatoid arthritis susceptibility among Han population in central plains of China. Asian Pac J Trop Med 6(1):73\u201375. \n                    https:\/\/doi.org\/10.1016\/S1995-7645(12)60204-1","journal-title":"Asian Pac J Trop Med"},{"issue":"1\u20132","key":"4288_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cca.2009.10.014","volume":"411","author":"F Pan","year":"2010","unstructured":"Pan F, Liao F, Xia G, Ge R, Mei Y, Tang X, Pan H, Ye D, Zou Y, Xu S, Xu J (2010) Association of IL-1F7 gene with susceptibility to human leukocyte antigen-B27 positive ankylosing spondylitis in Han Chinese population. Clin Chim Acta 411(1\u20132):124\u2013126. \n                    https:\/\/doi.org\/10.1016\/j.cca.2009.10.014","journal-title":"Clin Chim Acta"},{"key":"4288_CR11","doi-asserted-by":"publisher","unstructured":"Tan H, Deng B, Yu H, Yang Y, Ding L, Zhang Q, Qin J, Kijlstra A, Chen R, Yang P (2016) Genetic analysis of innate immunity in Beh\u00e7et\u2019s disease identifies an association with IL-37 and IL-18RAP. Sci Rep 6:35802. \n                    https:\/\/doi.org\/10.1038\/srep35802","DOI":"10.1038\/srep35802"},{"issue":"8697","key":"4288_CR12","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","year":"1990","unstructured":"Criteria for diagnosis of Beh\u00e7et\u2019s disease (1990) International study group for Beh\u00e7et\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"9","key":"4288_CR13","first-page":"854","volume":"58","author":"C Forbess","year":"2008","unstructured":"Forbess C, Swearingen C, Yazici Y (2008) Beh\u00e7et\u2019s syndrome activity score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with the Beh\u00e7et\u2019s disease current activity form (BDCAF). Arthritis Rheum 58(9):854","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4288_CR14","first-page":"77","volume":"31","author":"S Yilmaz","year":"2013","unstructured":"Yilmaz S, Simsek I, Cinar M, Erdem H, Kose O, Yazici Y, Pay S (2013) Patient-driven assessment of disease activity in Beh\u00e7et\u2019s syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Beh\u00e7et\u2019s syndrome activity score. Clin Exp Rheumatol 31(3):77\u201383","journal-title":"Clin Exp Rheumatol"},{"key":"4288_CR15","doi-asserted-by":"crossref","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG (2012) Primer3\u2014new capabilities and interfaces. Nucleic Acids Res 40(15): e115","DOI":"10.1093\/nar\/gks596"},{"key":"4288_CR16","doi-asserted-by":"crossref","unstructured":"Koressaar T, Remm M (2007) Enhancements and modifications of primer design program primer3. Bioinformatics 23(10):1289\u201391","DOI":"10.1093\/bioinformatics\/btm091"},{"key":"4288_CR17","doi-asserted-by":"publisher","unstructured":"Yin D, Naji DH, Xia Y, Li S, Bai Y, Jiang G, Zhao Y, Wang X, Huang Y, Chen S, Fa J, Tan C, Zhou M, Zhou Y, Wang L, Liu Y, Chen F, Liu J, Chen Q, Tu X, Xu C, Wang QK (2017) Genomic variant in IL-37 confers a significant risk of coronary artery disease. Sci Rep 7:42175. \n                    https:\/\/doi.org\/10.1038\/srep42175","DOI":"10.1038\/srep42175"},{"issue":"4","key":"4288_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/1566524014666140414210831","volume":"14","author":"Z Ye","year":"2014","unstructured":"Ye Z, Wang C, Kijlstra A, Zhou X, Yang P (2014) A possible role for interleukin-37 in the pathogenesis in Beh\u00e7et\u2019s disease. Curr Mol Med 14(4):535\u2013542","journal-title":"Curr Mol Med"},{"issue":"3","key":"4288_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, Italiani P, Nold MF, Nold-Petry CA, Bufler P, Dinarello CA (2011) IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22(3):127\u2013147. \n                    https:\/\/doi.org\/10.1684\/ecn.2011.0288","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"4288_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2133.2008.08696.x","volume":"159","author":"M Anthoni","year":"2008","unstructured":"Anthoni M, Fyhrquist-Vanni N, Wolff H, Alenius H, Lauerma A (2008) Transforming growth factor-beta\/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity. Br J Dermatol 159(3):546\u2013554. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08696.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"4288_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-018-1555-6","volume":"20","author":"H Chi","year":"2018","unstructured":"Chi H, Liu D, Sun Y, Hu Q, Liu H, Cheng X, Ye J, Shi H, Yin Y, Liu M, Wu X, Zhou Z, Teng J, Yang C, Su Y (2018) Interleukin-37 is increased in adult-onset Still\u2019s disease and associated with disease activity. Arthritis Res Ther 20(1):54. \n                    https:\/\/doi.org\/10.1186\/s13075-018-1555-6","journal-title":"Arthritis Res Ther"},{"key":"4288_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","volume":"21","author":"D Sarhan","year":"2018","unstructured":"Sarhan D, Hippen KL, Lemire A, Hying S, Luo X, Lenvik T, Curtsinger J, Davis Z, Zhang B, Cooley S, Cichocki F, Blazar BR, Miller JS (2018) Adaptive NK cells resist regulatory T cell suppression driven by IL-37. Cancer Immunol Res 21:766\u2013775. \n                    https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0498","journal-title":"Cancer Immunol Res"},{"key":"4288_CR23","doi-asserted-by":"publisher","unstructured":"L\u0130n XY, Guo XJ, He YZ, Hou SF, Zhu HB, Cheng Y, Nan Z (2018) Association between interleukin 37 (rs3811047) polymorphism and multiple autoimmune diseases in a Chinese population: a PRISMA-compliant meta-analysis. Medicine 97 (15): e0386. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000010386","DOI":"10.1097\/MD.0000000000010386"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4288-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:28:37Z","timestamp":1568762917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4288"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4288-7","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}